4.2 Editorial Material

Management of cytokine release syndrome: an update on emerging antigen-specific T cell engaging immunotherapies

Journal

IMMUNOTHERAPY
Volume 11, Issue 10, Pages 851-857

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/imt-2019-0074

Keywords

bispecific T cell engager; BiTE; CAR T cells; chimeric antigen receptor; CRS; cytokine release syndrome; immunotherapy; neurotoxicity

Categories

Funding

  1. Kite
  2. Gilead
  3. Tolero
  4. Morphosys
  5. Novartis
  6. Humanigen
  7. Lentigen
  8. [R01 NS 103212]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available